Pai, S., Yadav, V. K., Kuo, K., Pikatan, N. W., Lin, C., Chien, M., . . . Tsai, J. (2021). PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway. MDPI AG.
Style de citation Chicago (17e éd.)Pai, Shin, et al. PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway. MDPI AG, 2021.
Style de citation MLA (8e éd.)Pai, Shin, et al. PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway. MDPI AG, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.